Optimizing magnetic nanoparticle design for nanothermotherapy

Nanomedicine

Volumn 3, Issue 6, 2008, Pages 831-844

  Gazeau, Florence ^a   Lévy, Michael ^a   Wilhelm, Claire ^a  

^a UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Cancer; Hyperthermia; Magnetic nanoparticles; Magnetism; Targeting

Indexed keywords

ANTINEOPLASTIC AGENT; DENDRITIC CELL VACCINE; DEXTRAN; FERRIC OXIDE; HEAT SHOCK PROTEIN 70; LIPOSOME; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

BRAIN CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GENE THERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; EQUIPMENT DESIGN; GLIOBLASTOMA; GLIOMA; HUMAN; HYPERTHERMIC THERAPY; KIDNEY CANCER; MAGNETIC FIELD; MELANOMA; MICROWAVE THERAPY; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY; REVIEW; THERAPY EFFECT; TUMOR IMMUNITY; TUMOR REGRESSION; ULTRASOUND THERAPY;

ANIMALS; BIOPHYSICS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HOT TEMPERATURE; HYPERTHERMIA, INDUCED; MAGNETICS; MEDICAL ONCOLOGY; MICE; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; RATS;

EID: 57149125463     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.3.6.831     Document Type: Review

References (77)

1. Hildebrandt B, Wust P, Ahlers O et al.: The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43, 33-56 (2002).
2. Suto R, Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588 (1995).
3. Ito A, Shinkai M, Honda H et al.: Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol. Immunother. 52, 80-88 (2003).
4. Wust P, Hildebrandt B, Sreenivasa G et al.: Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487-497 (2002).
5. Mornet SV, Grasset S, Duguet F: Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14, 2161-2175 (2004).
6. Gilchrist, RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB: Selective inductive heating of lymph nodes. Ann. Surg. 146, 596-606 (1957).
7. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R: Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia 9, 51-68 (1993).
8. Rosensweig RE: Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252, 370-374 (2002).
9. 4particles in AC magnetic field. J. Magn. Magn. Mater. 268, 33-39 (2004).
10. Chan DCFK, Kirpotin DB, Bunn PA: In: Scientific and Clinical Applications of Magnetic Carriers. Häfeli WSU, Teller J, Zborowski M (Eds). Plenum Press, NY, USA 607 (1997).
11. Hergt RHR, Hilger I, Kaiser WA, Lapatnikov Y, Margel S, Richter U: Maghemite nanoparticles with very high AC-losses for application in RF-magnetic hyperthermia. J. Magn. Magn. Mater. 270, 345-357 (2004).
12. Hergt RHR, Zeisberger M, Schüler D, Heyen U, Hilger I, Kaiser WA: Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools. J. Magn. Magn. Mater. 293, 80-86 (2005).
13. Gupta, AK, Gupta M: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995-4021 (2005).
14. Fortin JP, Wilhelm C, Servais J, Menager C, Bacri JC, Gazeau F: Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129, 2628-2635 (2007).
15. Levy M, Wilhelm C, Siaugue JM, Horner J-C, Gazeau F: Magnetically induced hyperthermia: size dependent heating power of maghemite nanoparticles. J. Phys. Condens. Matter. 20, 204133 (2008).
16. Pradhan P, Giri J, Samanta G et al.: Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application. J. Biomed. Mater. Res. B Appl. Biomater. 81, 12-22 (2007).
17. Giri J, Pradhan P, Sriharsha T, Bahadur D: Preparation and investigation of potentiality of different soft ferrites for hyperthermia applications. J. Appl. Phys. 97, 916 (2005).
18. Zhao D-L, Xian-Wei Z, Qi-Sheng X, Tang J-T: Preparation and coercivity and saturation magnetization dependence of inductuve heating property of Fe3O4 nanoparticles in an alternating current magnetic field for localized hyperthermia. J. Alloys Compd doi:10.1016/ j.jallcom.2008.01.083 (2008) (Epub ahead of print).
19. Fortin JP, Gazeau F, Wilhelm C: Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles. Eur. Biophys. J. 37, 223-228 (2008).
20. Hadjipanayis CG, Bonder MJ, Balakrishnan S, Wang X, Mao H, Hadjipanayis GC: Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. Small 10.1002/smll.200800261 (2008) (Epub ahead of print).
21. Riviere C, Wilhelm C, Cousin F, Dupuis V, Gazeau F, Perzynski R: Internal structure of magnetic endosomes. Eur. Phys. J. E Soft Matter. 22, 1-10 (2007).
22. Wilhelm C, Fortin JP, Gazeau F: Tumor cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J. Nanosci. Nanotechnol. 7, 2933-2937 (2007).
23. Tang QS, Zhang DS, Cong XM, Wan ML, Jin LQ: Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression. Biomaterials 29, 2673-2679 (2008).
24. Vasseur S, Duguet E, Portier J et al.: Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermia. J. Magn. Magn. Mater. 302, 315-320 (2006).
25. Pollert E, Knízek K, Marysko M, Kaspar P, Vasseur S, Duguet E: New Tc-tuned magnetic nanoparticles for self-controlled hyperthermia. J. Magn. Magn. Mater. 316, 122-125 (2007).
26. Prasad NK, Rathinasamy K, Panda D, Bahadur D: TC-tuned biocompatible suspension of La0.73Sr0.27MnO3 for magnetic hyperthermia. J. Biomed. Mater. Res. B Appl. Biomater. 85, 409-416 (2008).
27. Martina MS, Fortin JP, Menager C et al.: Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J. Am. Chem. Soc. 127, 10676-10685 (2005).
28. Ito A, Kuga Y, Honda H et al.: Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett. 212, 167-175 (2004).
29. Wilhelm C, Lavialle F, Pechoux C, Tatischeff I, Gazeau F: Intracellular trafficking of magnetic nanoparticles to design multifunctional biovesicles. Small 4, 577-582 (2008).
30. Jordan A, Scholz R, Wust P et al.: Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 194, 185-196 (1999).
31. Jordan A, Scholz R, Wust P et al.: Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int. J. Hyperthermia 13, 587-605 (1997).
32. Hilger I, Andra W, Hergt R, Hiergeist R, Schubert H, Kaiser WA: Electromagnetic heating of breast tumors in interventional radiology:in vitroand in vivo studies in human cadavers and mice. Radiology 218, 570-575 (2001).
33. Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T: Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J. Biosci. Bioeng. 96, 364-369 (2003).
34. Johannsen M, Thiesen B, Jordan A et al.: Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 64, 283-292 (2005).
35. Johannsen M, Thiesen B, Gneveckow U et al.: Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 66, 97-104 (2006).
36. Kawai N, Ito A, Nakahara Y et al.: Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate 66, 718-727 (2006).
37. Kawai N, Futakuchi M, Yoshida T et al.: Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate 68, 784-792 (2008).
38. Ohno T, Wakabayashi T, Takemura A et al.: Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study. J. Neurooncol. 56, 233-239 (2002).
39. Jordan A, Scholz R, Maier-Hauff K et al.: The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol. 78, 7-14 (2006).
40. Takamatsu S, Matsui O, Gabata T et al.: Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat. Med. 26, 179-187 (2008).
41. Ito A, Tanaka K, Kondo K et al.: Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 94, 308-313 (2003).
42. Johannsen M, Gneveckow U, Thiesen B et al.: Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 52, 1653-1661 (2007).
43. Johannsen M, Gneveckow U, Taymoorian K et al.: Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective Phase I trial. Int. J. Hyperthermia 23, 315-323 (2007).
44. Johannsen M, Gneveckow U, Taymoorian K et al.: Thermal therapy of prostate cancer using magnetic nanoparticles. Actas Urol. Esp. 31, 660-667 (2007).
45. Maier-Hauff K, Rothe R, Scholz R et al.: Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 81, 53-60 (2007).
46. Jordan A, Maier-Hauff K: Magnetic nanoparticles for intracranial thermotherapy. J. Nanosci. Nanotechnol. 7, 4604-4606 (2007).
47. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T: Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J. Cancer Res. 87, 1179-1183 (1996).
48. Jordan A, Wust P, Scholz R et al.: Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int. J. Hyperthermia 12, 705-722 (1996).
49. Yan S, Zhang D, Gu N et al.: Therapeutic effect of Fe2O3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. J. Nanosci. Nanotechnol. 5, 1185-1192 (2005).
50. Ito A, Shinkai M, Honda H, Kobayashi T: Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 100, 1-11 (2005).
51. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T: Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J. Cancer Res. 89, 775-782. (1998).
52. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T: Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol. Immunother. 50, 515-522 (2001).
53. Ito A, Honda H, Kobayashi T: Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of 'heat-controlled necrosis' with heat shock protein expression. Cancer Immunol. Immunother. 55, 320-328 (2006).
54. Kawai N, Ito A, Nakahara Y et al.: Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 64, 373-381 (2005).
55. Tanaka K, Ito A, Kobayashi T et al.: Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int. J. Cancer 116, 624-633 (2005).
56. Ito A, Matsuoka F, Honda H, Kobayashi T: Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Ther. 10, 918-925 (2003).
57. Ito A, Shinkai M, Honda H, Kobayashi T: Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 8, 649-654 (2001).
58. Shinkai M, Suzuki M, Iijima S, Kobayashi T: Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia. Biotechnol. Appl. Biochem. 21(Pt 2), 125-137 (1995).
59. DeNardo SJ, DeNardo GL, Miers LA et al.: Development of tumor targeting bioprobes 111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin. Cancer Res. 11, 7087s-7092s (2005).
60. Montet X, Montet-Abou K, Reynolds F, Weissleder R, Josephson L: Nanoparticle imaging of integrins on tumor cells. Neoplasia 8, 214-222 (2006).
61. Sonvico F, Mornet S, Vasseur S et al.: Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia M ediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem. 16, 1181-1188 (2005).
62. Gordon RT, Hines JR, Gordon D: Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med. Hypotheses 5, 83-102 (1979).
63. Rabin Y: Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int. J. Hyperthermia 18, 194-202 (2002).
64. Shinkai M, Le B, Honda H et al.: Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn J. Cancer Res. 92, 1138-1145 (2001).
65. Mitsumori M, Hiraoka M, Shibata T et al.: Development of intra-arterial hyperthermia using a dextran-magnetite complex. Int. J. Hyperthermia 10, 785-793 (1994).
66. Moroz P, Jones SK, Winter J, Gray BN: Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model. J. Surg. Oncol. 78, 22-29; discussion 30-31 (2001).
67. Moroz P, Jones SK, Gray BN: Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model. J. Surg. Oncol. 80, 149-156 (2002).
68. Minamimura T, Sato H, Kasaoka S et al.: Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microsphere in rats. Int. J. Oncol. 16, 1153-1158 (2000).
69. Fortin-Ripoche JP, Martina MS, Gazeau F et al.: Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Radiology 239, 415-424 (2006).
70. Riviere C, Martina MS, Tomita Y et al.: Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice. Radiology 244, 439-448 (2007).
71. Kwon SG, Hyeon T: Colloidal chemical synthesis and formation kinetics of uniformly sized nanocrystals of metals, oxides, and chalcogenides. Acc. Chem. Res. (2008) (Epub ahead of print).
72. Figuerola A, Fiore A, Di Corato R et al.: One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals. J. Am. Chem. Soc. 130, 1477-1487 (2008).
73. Cozzoli, PD, Pellegrino T, Manna L: Synthesis, properties and perspectives of hybrid nanocrystal structures. Chem. Soc. Rev. 35, 1195-1208 (2006).
74. Viroonchatapan E, Sato H, Ueno M, Adachi I, Tazawa K, Horikoshi I: Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system. Life Sci. 5 8, 2251-2261 (1996).
75. Massart, R: Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 17, 1247-1248 (1981).
76. Wilhelm C, Gazeau F: Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161-3174 (2008).
77. Ito A, Matsuoka F, Honda H, Kobayashi T: Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol. Immunother. 53, 26-32 (2004).